Building towards a future of improved healthcare across global markets



Prof. Lugee Li is the founder and sole shareholder of Leader Biomedical Group. Originally a materials engineer, Prof. Lugee Li is also the Founder and Chairman of Dongguan Eontec, a new materials company listed on the Shenzen Stock exchange.

Prof. Lugee Li currently heads China’s magnesium research initiate, which led him to team up with German companies to investigate the applications of magnesium in the medical field. It is this initiative that led to his entry into the field of medical devices.

2012: Foundation

Prof. Lugee Li recruits Leo Liyeung, Lili Yao, and Isaac Bresnick to help found Leader Biomedical.

2013: Acquisition of aap Joints

Prof. Lugee Li acquires a majority stake in aap Joints, the reconstructive implants division of aap Implantate in Berlin, Germany.

2014: Acquisition of EMCM and formation of Leader Biomedical Group

Having identified the synergies between biomaterials and surgical implants within the Chinese market, Prof. Lugee Li acquired EMCM, a biomaterials contract manufacturer, from aap Implantate. Subsequent to the acquisition, an organisation was established to support the future growth plans of the business with the appointment of Basil Babychan to the Board of Management and the establishment of Leader Biomedical’s HQ in Hong Kong, China, and Leader Biomedical Europe in Amsterdam, the Netherlands.

2015: Global expansion of Leader Biomedical Group

Leader Biomedical expanded its global footprint with the establishment of Leader Biomedical Brazil, in Sao Paulo, and Leader Biomedical India, in Bangalore.


2016: Further increase of Leader Biomedical Group’s global footprint

Leader Biomedical Group partners with BioTiss Austria in new eCOO® Technology venture and establishes two more regional ventures with Leader Biomedical Leader Biomedical RUS, LLC, in Moscow, in the Russian Federation, and Leader Biomedical ASIA PACIFIC SDN.BHD (Leader Biomedical APAC), in Selangor, Malaysia .